Must See: Do You Invest in Midcap Stocks? Here's a Great News for You
Here is the latest financial fact sheet of DR LALCHANDANI LABS. For more details, see the DR LALCHANDANI LABS quarterly results and DR LALCHANDANI LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -4.8 |
No. of shares | m | 4.33 |
1 Week | % | 20.5 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 35.0/15.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DR LALCHANDANI LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 32 | 22 | 18 | 53 | 45 | |
Low | Rs | 18 | 8 | 7 | 13 | 19 | |
Sales per share (Unadj.) | Rs | 12.2 | 14.1 | 22.6 | 26.0 | 11.6 | |
Earnings per share (Unadj.) | Rs | 1.2 | 1.1 | 2.3 | 2.2 | -3.6 | |
Diluted earnings per share | Rs | 1.2 | 1.1 | 2.3 | 2.2 | -3.6 | |
Cash flow per share (Unadj.) | Rs | 2.0 | 2.1 | 3.5 | 3.5 | -2.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 18.6 | 19.7 | 22.1 | 24.2 | 20.6 | |
Adj. book value per share | Rs | 18.6 | 19.7 | 22.0 | 24.2 | 20.6 | |
Shares outstanding (eoy) | m | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 | |
Price / Sales ratio | x | 2.0 | 1.1 | 0.5 | 1.3 | 2.7 | |
Avg P/E ratio | x | 19.9 | 13.6 | 5.2 | 15.3 | -8.8 | |
P/CF ratio (eoy) | x | 12.0 | 7.2 | 3.4 | 9.4 | -15.2 | |
Price / Book Value ratio | x | 1.3 | 0.8 | 0.6 | 1.4 | 1.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 106 | 65 | 53 | 142 | 137 | |
Total wages/salary | Rs m | 7 | 6 | 4 | 11 | 11 |
DR LALCHANDANI LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 53 | 61 | 98 | 113 | 50 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 53 | 61 | 98 | 113 | 50 | |
Gross profit | Rs m | 12 | 13 | 22 | 25 | 1 | |
Depreciation | Rs m | 3 | 4 | 5 | 6 | 7 | |
Interest | Rs m | 1 | 2 | 4 | 6 | 10 | |
Profit before tax | Rs m | 7 | 7 | 14 | 13 | -16 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2 | 2 | 4 | 4 | 0 | |
Profit after tax | Rs m | 5 | 5 | 10 | 9 | -16 | |
Gross profit margin | % | 22.8 | 20.8 | 23.0 | 21.9 | 1.8 | |
Effective tax rate | % | 25.8 | 28.2 | 26.6 | 27.5 | 0 | |
Net profit margin | % | 10.1 | 7.8 | 10.3 | 8.3 | -31.0 |
DR LALCHANDANI LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 58 | 76 | 86 | 108 | 110 | |
Current liabilities | Rs m | 14 | 19 | 29 | 49 | 53 | |
Net working cap to sales | % | 84.1 | 93.5 | 58.2 | 52.7 | 113.1 | |
Current ratio | x | 4.1 | 4.1 | 3.0 | 2.2 | 2.1 | |
Inventory Days | Days | 39 | 33 | 43 | 47 | 95 | |
Debtors Days | Days | 126,776,468 | 198,974,733 | 1,486 | 1,364 | 3,596 | |
Net fixed assets | Rs m | 38 | 40 | 64 | 72 | 67 | |
Share capital | Rs m | 43 | 43 | 43 | 43 | 43 | |
"Free" reserves | Rs m | 37 | 42 | 52 | 62 | 46 | |
Net worth | Rs m | 81 | 85 | 96 | 105 | 89 | |
Long term debt | Rs m | 6 | 15 | 26 | 26 | 33 | |
Total assets | Rs m | 101 | 119 | 152 | 181 | 177 | |
Interest coverage | x | 6.3 | 4.6 | 4.9 | 3.2 | -0.6 | |
Debt to equity ratio | x | 0.1 | 0.2 | 0.3 | 0.2 | 0.4 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.6 | 0.6 | 0.3 | |
Return on assets | % | 6.6 | 5.5 | 9.0 | 8.4 | -3.2 | |
Return on equity | % | 6.6 | 5.6 | 10.6 | 8.9 | -17.5 | |
Return on capital | % | 9.9 | 8.5 | 14.2 | 14.4 | -4.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
DR LALCHANDANI LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -4 | -1 | 12 | 20 | 0 | |
From Investments | Rs m | -19 | -5 | -23 | -15 | -2 | |
From Financial Activity | Rs m | 35 | 9 | 17 | 2 | -2 | |
Net Cashflow | Rs m | 11 | 2 | 6 | 6 | -4 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: Arjan Lalchandani | COMP SEC: Archana R Jha | YEAR OF INC: 2011 | BSE CODE: 541299 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare DR LALCHANDANI LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.